NASDAQ:CLVS
Clovis Oncology, Inc.
- Stock
Last Close
0.08
20/12 21:00
Volume Today
24.21M
Avg: 5.97M
PE Ratio
−0.06
PFCF: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|---|
revenue | 13.63M - | 78K - | 55.51M 71,067.95% | 95.39M 71.84% | 143.01M 49.92% | 164.52M 15.05% | 148.76M 9.58% | |||
cost of revenue | 83.77M - | 158.46M 89.17% | 376.72M 137.74% | 70K 99.98% | 11.74M 16,667.14% | 22.07M 88.07% | 34.69M 57.14% | 41.30M 19.08% | 38.83M 6.00% | |
gross profit | -83.77M - | -144.83M 72.90% | -376.72M 160.11% | 8K 100.00% | 43.77M 547,075% | 73.31M 67.48% | 108.32M 47.75% | 123.22M 13.75% | 109.93M 10.78% | |
selling and marketing expenses | ||||||||||
general and administrative expenses | 16.57M - | 21.46M 29.52% | 30.52M 42.26% | 40.73M 33.44% | 138.91M 241.04% | 175.78M 26.55% | 182.77M 3.98% | |||
selling general and administrative expenses | 16.57M - | 21.46M 29.52% | 30.52M 42.26% | 40.73M 33.44% | 138.91M 241.04% | 175.78M 26.55% | 182.77M 3.98% | 163.89M 10.33% | 128.40M 21.66% | |
research and development expenses | 66.55M - | 137.71M 106.94% | 269.25M 95.53% | 251.13M 6.73% | 142.50M 43.26% | 231.35M 62.35% | 283.15M 22.39% | 257.71M 8.98% | 192.08M 25.47% | |
other expenses | 9.71M - | 167.70M 1,626.89% | 15.22M 90.92% | |||||||
cost and expenses | 83.11M - | 159.16M 91.50% | 299.77M 88.35% | 291.93M 2.62% | 293.14M 0.42% | 429.20M 46.41% | 510.31M 18.90% | 466.71M 8.54% | 374.52M 19.75% | |
operating expenses | 83.11M - | 159.16M 91.50% | 299.77M 88.35% | 291.86M 2.64% | 281.40M 3.58% | 407.13M 44.68% | 475.63M 16.82% | 425.40M 10.56% | 335.70M 21.09% | |
interest expense | 2.60M - | 8.37M 221.51% | 8.49M 1.42% | 10.43M 22.81% | 13.18M 26.42% | 16.55M 25.52% | 23.49M 41.97% | 31.67M 34.83% | ||
ebitda | -84.23M - | -150.90M 79.15% | -372.80M 147.06% | -371.54M 0.34% | -337.04M 9.28% | -349.62M 3.73% | -374.31M 7.06% | -338.07M 9.68% | -224.76M 33.52% | |
operating income | -83.77M - | -158.46M 89.17% | -376.72M 137.74% | -372.73M 1.06% | -237.63M 36.25% | -333.81M 40.48% | -376.75M 12.86% | -302.19M 19.79% | -233.25M 22.81% | |
depreciation and amortization | 250K - | 4.22M 1,588% | 761K 81.97% | 1.14M 49.93% | 2.50M 119.46% | 4.60M 83.75% | 7.77M 68.83% | 8.20M 5.54% | 8.50M 3.64% | |
total other income expenses net | -713K - | 736K 203.23% | -5.22M 808.70% | -8.44M 61.77% | -112.34M 1,231.41% | -33.59M 70.10% | -21.88M 34.86% | -67.57M 208.83% | -31.67M 53.13% | |
income before tax | -84.48M - | -157.72M 86.70% | -381.94M 142.16% | -381.17M 0.20% | -349.98M 8.18% | -367.40M 4.98% | -398.63M 8.50% | -369.76M 7.24% | -264.93M 28.35% | |
income tax expense | 52K - | 2.31M 4,338.46% | -29.08M 1,359.79% | -32.03M 10.17% | -3.58M 88.83% | 608K 116.99% | 1.80M 195.72% | -547K 130.42% | -404K 26.14% | |
net income | -84.53M - | -160.03M 89.31% | -352.86M 120.50% | -349.14M 1.06% | -346.40M 0.78% | -368.01M 6.24% | -400.42M 8.81% | -369.21M 7.79% | -264.52M 28.35% | |
weighted average shs out | 28.67M - | 33.89M 18.20% | 36.03M 6.31% | 38.48M 6.81% | 47.05M 22.27% | 52.07M 10.67% | 53.87M 3.47% | 84.31M 56.49% | 121.22M 43.78% | |
weighted average shs out dil | 28.67M - | 33.89M 18.20% | 36.03M 6.31% | 38.48M 6.81% | 47.05M 22.27% | 52.07M 10.67% | 53.87M 3.47% | 84.31M 56.49% | 121.22M 43.78% | |
eps | -2.95 - | -4.72 60.00% | -9.79 107.42% | -9.07 7.35% | -7.36 18.85% | -7.07 3.94% | -7.43 5.09% | -4.38 41.05% | -2.18 50.23% | |
epsdiluted | -2.95 - | -4.72 60.00% | -9.79 107.42% | -9.07 7.35% | -7.36 18.85% | -7.07 3.94% | -7.43 5.09% | -4.38 41.05% | -2.18 50.23% |
All numbers in USD (except ratios and percentages)